**Why J&J Has Been Fined $966M in the US**
*By Dwaipayan Roy | Oct 08, 2025, 05:15 PM*
Johnson & Johnson (J&J) has been ordered by a Los Angeles jury to pay $966 million to the family of a woman who died from mesothelioma, a rare form of cancer. This ruling follows the jury’s finding that the company’s talc products were linked to cancer.
### Background of the Case
The lawsuit was filed by the family of Mae Moore, an 88-year-old California resident who passed away in 2021. The family initiated the case against J&J in the same year, alleging that the company’s talc products contributed to her illness.
### Verdict Details
The jury awarded $16 million in compensatory damages and an astounding $950 million in punitive damages against J&J. In response, Erik Haas, J&J’s global vice president of litigation, announced the company’s intention to appeal the decision. He described the verdict as “egregious and unconstitutional” and criticized the plaintiff lawyers for relying on what he called “junk science” that should not have been admitted in court.
### Product Safety and Company Response
Despite the verdict, J&J maintains that its talc-based products are safe, contain no asbestos, and do not cause cancer. The company discontinued sales of talc-based baby powder in the United States in 2020, transitioning to a cornstarch-based alternative. It is important to note that mesothelioma has been medically linked to asbestos exposure.
Trey Branham, attorney for Moore’s family, expressed hope that this ruling will finally hold Johnson & Johnson accountable for what he termed “senseless deaths.”
### Ongoing Litigation
Johnson & Johnson currently faces over 67,000 lawsuits alleging cancer caused by its baby powder and other talc products. While the majority of these claims relate to ovarian cancer, mesothelioma cases form a smaller portion of the litigation.
The company has attempted to resolve the mass litigation by filing for bankruptcy protection, but three such proposals have been rejected by federal courts.
### Settlement and Trial Landscape
Though J&J has settled some mesothelioma claims, it has yet to achieve a nationwide settlement agreement. Consequently, many mesothelioma lawsuits have proceeded to trial in various state courts over recent months.
In the past year alone, J&J has faced several significant verdicts related to mesothelioma, with Monday’s ruling representing one of the largest monetary penalties to date. The company has, however, successfully reduced some awards on appeal, including a $260 million verdict overturned by a state judge in Oregon.
—
This recent verdict underscores the ongoing legal challenges Johnson & Johnson faces concerning its talc products and the serious claims raised by affected consumers and their families. The company’s appeal process will be closely watched as these cases continue to unfold.
https://www.newsbytesapp.com/news/business/j-j-hit-with-966m-verdict-in-talc-cancer-trial/story
Be First to Comment